Torsades de pointes complicating atrioventricular block: Evidence for a genetic predisposition

Heart Rhythm

Volumn 4, Issue 2, 2007, Pages 170-174

  Chevalier, Philippe ^a   Bellocq, Chloé ^b   Millat, Gilles ^a   Piqueras, Eric ^a   Potet, Franck ^b   Schott, Jean Jacques ^b   Baró, Isabelle ^b   Lemarec, Hervé ^b   Barhanin, Jacques ^c   Rousson, Robert ^a   Rodriguez Lafrasse, Claire ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b L INSTITUT DU THORAX   (France)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Atrioventricular block; HERG mutation; Long QT interval; Torsades de pointes

Indexed keywords

ARGININE; CYSTEINE; FLECAINIDE; LEUCINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL SCN5A; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARRHYTHMOGENESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HEART REPOLARIZATION; HEREDITY; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; RETROSPECTIVE STUDY; RISK FACTOR; TORSADE DES POINTES; VOLUNTEER; WILD TYPE;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART BLOCK; HUMANS; MALE; MUTATION; POTASSIUM CHANNELS; RETROSPECTIVE STUDIES; TORSADES DE POINTES;

EID: 33846576733     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.10.004     Document Type: Article

References (21)

1. Vincent G.M. The long-QT syndrome-bedside to bench to bedside. N Engl J Med 348 (2003) 1837-1838
2. Dessertenne F. La tachycardie ventriculaire à deux foyers opposés variables. Arch Mal Coeur Vaiss 2 (1966) 263-272
3. Jensen G., Sigurd B., and Sandoe E. Adams-Stokes seizures due to ventricular tachydysarrhythmias in patients with heart block: prevalence and problems of management. Chest 67 (1975) 43-48
4. Motté G., Coumel P., Abitbol G., Dessertenne F., and Slama R. Le syndrome du QT long et syncopes par torsades de pointes. Arch Mal Coeur Vaiss 63 (1970) 831-853
5. Guize L., Iliou M.C., Bayet G., Lavergne T., and Le Heuzey J.Y. Les torsades de pointes. Arch Mal Coeur Vaiss 86 (1993) 769-776
6. Kurita T., Ohe T., Marui Aihara N., Takaki H., Kamakura S., Matsuhisa M., and Shimomura K.N. Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. Am J Cardiol 69 (1992) 628-633
7. Van Opstal J.M., Verduyn S.C., Leunissen H.D., de Groot S.H., Wellens H., and Vos M.A. Electrophysiological parameters indicative of sudden cardiac death in the dog with chronic complete AV-block. Cardiovasc Res 50 (2001) 354-361
8. Roden D.M. Taking the idio out of idiosyncratic: predicting torsades de pointes. Pacing Clin Electrophysiol 21 (1998) 1029-1034
9. Chevalier P., Rodriguez C., Bontemps L Miquel M., Kirkorian G., Rousson R., Potet F., Schott J.J., Baro I., and Touboul P. Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates. Cardiovasc Res 50 (2001) 386-398
10. Millat G., Chevalier P., Restier-Miron L., Da Costa A., Bouvagnet P., Kugener P., Fayol L., Gonzales Armengod C., Oddou B., Chanavat V., Froidefond E., Perraudin R., Rousson R., and Rodriguez-Lafrasse C. Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin Genet 70 (2006) 214-227
11. Loussouarn G., Charpentier F., Mohammad-Panah R., Kunzelmann K., Baro I., and Escande D. KvLQT1 potassium channel but not Isk is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2.2-dimethyl-c hromane. Mol Pharmacol 52 (1997) 1131-1136
12. + channel. J Pharmacol Exp Ther 299 (2001) 1007-1012
13. Geelen P., Brugada J., Andries E., and Brugada P. Ventricular fibrillation and sudden cardiac death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 20 (1997) 343-348
14. Vos M.A., De Groot S.H., Verduyn S.C., van der Zande J., Leunissen H.D., Cleutjens J.P., van Bilsen M., Daemen M.J., Schreuder J.J., Allessie M.A., and Wellens H.J. Enhanced susceptibility for acquired torsades de pointes arrhythmias in the dog with chronic complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 98 (1998) 1125-1135
15. Volders P.J., Sipido K.R., Vos MA Spatjens R.L., Leunissen J.D., Carmeliet E., and Wellens H.J. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 100 (1999) 2455-2461
16. Tsuji Y., Opthof T., Yasui K., Inden Y., Takemura H., Niwa N., Honjo H., Kamiya K., and Kodama I. Ionic mechanisms of acquired QT prolongation and torsades de pointes in rabbits with chronic complete atrioventricular block. Circulation 106 (2002) 2012-2018
17. Yoshida H., Horie M., Otani H., Kawashima T., Onishi Y., and Sasayama S. Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG. Am J Med Genet 98 (2001) 348-352
18. Volders P.G.A., Sipido K.R., Vos M.A., Kulcsár A., Verduyn S.C., and Wellens H.J.J. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes. Circulation 98 (1998) 1136-1147
19. Kr. Implications for torsade de pointes and reverse use-dependence. Circulation 93 (1996) 407-411
20. Berthet M., Denjoy I., and Donger C. C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation 99 (1999) 1464-1470
21. Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P.C., Hohnloser S.H., Shimizu W., Schwartz P.J., Stanton M., Murray K.T., Norris K., George Jr. A.L., and Roden D.M. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105 (2002) 1943-1948